Abstract
Inflammation is the main contributing factor for many eye disorders and may lead to decreased vision and even blindness. In the treatment of intraocular inflammation in general, glucocorticoids are frequently administered medications. However, the collateral effect of these pharmaco, as the rise of the pressure to intraocular, cataractogenesis and potential cytotoxicity to the structures …